111Indium antimyosin antibody imaging of primary myocardial involvement in systemic diseases

Annals of the Rheumatic Diseases

Volumn 58, Issue 2, 1999, Pages 90-95

  Sarda, L ^a   Assayag, P ^a   Palazzo, E ^a   Vilain, D ^a   Guillevin, L ^b   Faraggi, M ^a   Meyer, O ^a   Le Guludec, D ^a  

^a BICHAT HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; MYOSIN ANTIBODY IN 111; THALLIUM 201; AUTOANTIBODY; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; INDIUM; MYOSIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; SYSTEMIC DISEASE; CARDIOMYOPATHY; CONNECTIVE TISSUE DISEASE; ECHOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART; IMMUNOLOGY; MIDDLE AGED; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; AUTOANTIBODIES; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CONNECTIVE TISSUE DISEASES; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; MYOSINS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES;

EID: 0033072464     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.2.90     Document Type: Article

References (31)

1. 1 Coblyn JS, Weinblatt ME. Rheumatic disease and the heart. 5th ed. Braunwald E, ed. Heart disease. Philadelphia: Saunders, 1997:1776-85.
2. 2 Chow LH, Radio SJ, Sears TD, McManus BM. Insensitivity of right endomyocardial biopsy in the diagnosis of myocarditis. J Am Coll Cardiol 1989;14:915-20.
3. 3 McKenna WJ, Davies MJ. Immunosuppression for myocarditis. N Engl J Med 1995;333:312-13.
4. 4 Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995;333:269-75.
5. 5 Khaw BA, Scott J, Fallon JT, Haber E. Myocardial injury quantitation by cell sorting method with antimyosin fluorescent spheres. Science 1982;217:1050-3.
6. 6 Le Guludec D, Lhote F, Weinmann P, Royer I, Jarrousse B, Caillat-Vigneron N, et al. New application of myocardial antimyosin scintigraphy: diagnosis of myocardial disease in polymyositis. Ann Rheum Dis 1993;52:235-8.
7. 7 Denbow CE, Lie T, Tancredi RG, Burch JW. Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 1979;22:1088-92.
8. 8 Rechavia E, Rotenberg Z, Fuchs J, Strasberg B. Polymyositic heart disease. Chest 1985;88:309-11.
9. 9 Tami LF, Bhasin S. Polymorphism of cardiac manifestations in dermatomyositis. Clin Cardiol 1993;16:260-4.
10. 10 Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis, a cause of cardiac dysfunction. Circulation 1976;53:483-90.
11. 11 Hasley PB, Folansbee WP, Coulehan JL. Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. Am Heart J 1990;120:996-9.
12. 12 Sharma OP. Myocardial sarcoidosis: a wolf in sheep's clothing. Chest 1994;106:988-91.
13. 13 Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110: 1257-64.
14. 14 De Innocencio J, Lovell J. Cardiac function in systemic lupus erythematosus. J Rheumatol, 1994;21:2147-56.
15. 15 Janosyk DL, Osborn TG, Moore TL, Shah DG, Kenney RG, Zuckner J. Heart disease in systemic sclerosis. Semin Arthritis Rheum 1989;19:191-200.
16. 16 Kahan A, Devaux JY, Amor B, Menkes CJ, Weber S, Foult JM, et al. Pharmacodynamic effect of dipyridamole on TI-201 myocardial perfusion in progressive systemic sclerosis with diffuse scleroderma. Ann Rheum Dis 1986;45:718-25.
17. 17 Kahan A, Devaux JY, Amor B, Menkes CJ, Weber S, Nitenberg A, et al. Nifedipine and TI-201 myocardial perfusion in progressive systemic sclerosis. N Engl J Med 1986;314: 1397-402.
18. 18 Le Guludec D, Menad F, Faraggi M, Weinman P, Battesti JP, Valeyre D. Myocardial sarcoisosis: clinical value of technetium-99m sestamibi tomoscintigraphy. Chest 1994; 106:1675-82.
19. 19 Follansbec WP, Zerbe TR, Medsger TA. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): a high risk association. Am Heart J 1993;125:194-203.
20. 20 Davidson CJ, Fishman RF, Bonow RO. Cardiac catheterization. In: Braunwald E, ed. Heart disease. Philadelphia: Saunders, 1997:1202-4.
21. 21 Johnson LL, Seldin DW, Becker LC, Lafrance ND, Liberman HA, James C, et al. Antimyosin imaging in acute transmural myocardial infarctions: results of a multicenter clinical trial. J Am Clin Cardiol 1989;13:27-35.
22. 22 Obrador D, Ballester M, Carrio I, Berna L, Pons-Llado G. High prevalence of myocardial antimyosin antibody uptake in patients with chronic idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989;13:1289-93.
23. 23 Carrio I, Berna L, Ballester M, Estorch M, Obrador D, Cladellas M, et al. Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med, 1988;12:1893-900.
24. 24 Carrio I, Estorch M, Berna L, Duncker C, Torres G. Cumulative dose of doxorubicin and seventy of myocardial damage assessed by antimyosin monoclonal antibody studies. [Abstract]. J Nucl Med 1991;32:1019-20.
25. 25 Ballester MD, Marti V, Carrio I, Obrador D, Moya C, PonsLlado G, et al. Spectrum of alcohol-induced myocardial damage detected by In-111-labelled monoclonal antimyosin antibodies. J Am Coll Cardiol 1997;29:160-7.
26. 26 Dec GW, Palacios IF, Yasuda T, Fallon JT, Khaw BA, Strauss HW, et al. Antimyosin antibody cardiac imaging: its role in the diagnosis of myocarditis. J Am Clin Cardiol 1990;16:97-104.
27. 27 Narula J, Khaw BA, Dec W, Palacios IF, Newell JB, Southern JF, et al. Diagnostic accuracy of antimyosin scintigraphy in suspected myocarditis. J Nucl Cardiol 1996;3:371-81.
28. 28 Morguet AJ, Sandrock D, Stille-Siegener M, Figulla HR. In-111-antimyosin Fab imaging to demonstrate myocardial involvement in systemic lupus erythematosus. J Nucl Med 1995;36:1432-5.
29. 29 Knapp WH, Bentrup A, Ohlmeier H. In-111-labelled antimyosin antibody imaging in a patient with cardiac sarcoidosis. Eur J Nucl Med 1993;20:80-2.
30. 111In-antimyosin-scintigraphy for the diagnosis of myocardial damage in systemic sclerosis. J Nucl Med 1998;38:1759-61.
31. 31 Lange LG, Schreiner GF. Immune mechanisms of cardiac disease. N Engl J Med 1994;330:1129-35.